{
  "id": 7803079,
  "title": "Halozyme at H.C. Wainwright conference: royalties drive growth",
  "url": "https://urgent.news/2026/09/16/halozyme-at-h-c-wainwright-conference-royalties-drive-growth",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-16T14:36:19.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/transcripts/halozyme-at-hc-wainwright-conference-royalties-drive-growth-93CH-4904014"
  },
  "original_language": "en",
  "account": "On September 16, 2026, Halozyme (HALO) showcased its business growth at the H.C. Wainwright 28th Annual Global Investment Conference, focusing on fast-growing royalty streams, new platform deals, and an expanding patent base. Management highlighted strong near-term momentum, while acknowledging that some ENHANZE royalties might decrease later in the decade as certain IP expires in specific markets. In Q2 2026, the company reported record revenue of $481 million, up 48% YoY, primarily driven by 50% growth in royalty revenue to $308 million. The company raised its full-year 2024 guidance to $1.835 billion to $1.91 billion, with adjusted EPS possibly reaching $9.00. Management stated that ENHANZE continues to attract new partners, and the Hypercon platform adds another growth layer. Although some royalty step-downs are expected starting in 2029, co-formulation patents and new products should help mitigate the impact. Halozyme expects little to no impact from the Inflation Reduction Act through 2035. CEO Helen Torley emphasized the company's strong operating leverage and growing royalty base, noting that total revenue grew 48% YoY to $481 million, with royalty revenue accounting for about 64% of total revenue. Adjusted EBIT margin stood at 67%, reflecting the company's asset-light model.",
  "summary": null,
  "key_points": [
    "Halozyme reported $481 million revenue in Q2 2026, up 48% YoY",
    "64% of total revenue came from royalties in 2026",
    "CEO Helen Torley highlighted strong operating leverage and royalty base"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Myomo at H.C. Wainwright conference: referral shift drives growth",
        "url": "https://urgent.news/2026/09/16/myomo-at-h-c-wainwright-conference-referral-shift-drives-growth",
        "published": "2026-09-16T15:20:53.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}